Orion’s Nubeqa to Exceed €1 Billion in Long‑Term Revenue, Powering 2026 GrowthOrion’s Nubeqa sales projected to top €1 billion, driven by solid phase III data, EU approvals and high‑margin oncology revenue growth.Orion Oyj B Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Dr. Michael Chen 16/01/2026, 00:50 4 minutes to read
